ALBIOS: Albumin Replacement in Patients with Severe Sepsis or Septic Shock Randomised, controlled clinical trial; Stratified according to. In this icTV interview video, Luciano Gattinoni discusses his recent trial: Albumin for Volume Replacement in Severe Sepsis (ALBIOS). BACKGROUND: A reanalysis of the ALBIOS trial suggested that patients with septic shock – defined by vasopressor-dependent hypotension in.

Author: Kazizil Samusho
Country: Madagascar
Language: English (Spanish)
Genre: Travel
Published (Last): 21 August 2007
Pages: 218
PDF File Size: 13.8 Mb
ePub File Size: 13.73 Mb
ISBN: 882-4-24562-535-9
Downloads: 71556
Price: Free* [*Free Regsitration Required]
Uploader: Kishicage

Follow me on Twitter My Tweets. Strangely, no analysis of the primary outcome for this subgroup was presented by the authors. Another interesting thing would have been to know the infusion time of the albumin, since animal data tells us that a 3hr infusion decreases extravasation and improves vascular filling vs shorter infusion times.

Human nature for some I guess. The authors explain that the coagulation and liver dysfunction was due to “a higher serum bilirubin and a lower platelet count” rather than being a reflection of clinically-significant physiologic parameters. Sorry, your blog cannot share posts by email. Again, studies such as EGDT are pivotal in changing practice and raising awareness, so this is not a knock against a necessary study, just to highlight the point that each study is a step along the way of refining our resuscitation, and the important thing is to move on.


Meets criteria for SIRS. Notify me of follow-up comments by email. Introduction to Statistics for Nurses.

thinking critical care

Registered on 30 June A subgroup analysis of the secondary outcome of 90 day all-cause mortality demonstrated a survival advantage for albumin therapy in those in septic shock at enrollment. A large randomized controlled trial to evaluate for benefit of albumin in patients with severe sepsis or septic shock was lacking.

Courtesy of Felix Views Read View source View history. Thinkingcriticalcare has the view that this study confirms their belief that giving albumin is safe practice…. EM Lyceum triao everything rtial up for debate. Kudos to all investigators.

So, what does this mean. Ketamine with raised ICP? A reanalysis of the ALBIOS trial suggested that patients with septic shock – defined by vasopressor-dependent hypotension in the presence of severe sepsis Shock-2 – had a survival benefit when treated with albumin.

Caironi P, et al. This page was last modified on 3 Julyat Wash Albiso Mouth Out!!


ALBIOS – The Bottom Line

However, this finding should be used for hypothesis-building purposes given its post-hoc nature. As the authors note, their mortality was low, so again may not have been able to detect a difference. Jones- Is Lactate a Useful Indicator?

A pilot trial by Dubois et al. Navigation menu Personal tools Create account Log in.

Get my feet to the floor…please! Gavin raises his legs!! Notify me of new posts by email. Albumin in Severe Sepsis?

They also note the underpowered-ness of their own study, but I think it is still worth looking at their results. Ok, so it was pretty cool to see an NEJM issue basically dedicated to septic shock management, I must admit. So basically showed no difference, so pretty much a solid italian remake of the SAFE study in a sense, confirming that albumin is indeed safe overall, and may be better in those with shock. Republished by Blog Post Promoter.

Author: admin